These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 23364701)

  • 61. [Total pelvic exenteration for primary and locally recurrent rectal cancer].
    Takagi H; Morimoto T; Kato T; Yasue M; Kato K; Yamada E; Hara S; Kido C; Suzuki R; Kuwabara M
    Gan No Rinsho; 1984 Nov; 30(14):1779-85. PubMed ID: 6513031
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Sacral resection in surgical treatment of locally advanced primary and recurrent rectal and anal cancer: short-term outcomes].
    Tsarkov PV; Efetov SK; Sidorova LV; Tulina IA
    Khirurgiia (Mosk); 2017; (7):4-13. PubMed ID: 28745699
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The Importance of a Minimal Tumor-Free Resection Margin in Locally Recurrent Rectal Cancer.
    Alberda WJ; Verhoef C; Schipper ME; Nuyttens JJ; Rothbarth J; de Wilt JH; Burger JW
    Dis Colon Rectum; 2015 Jul; 58(7):677-85. PubMed ID: 26200682
    [TBL] [Abstract][Full Text] [Related]  

  • 64. High Level Sacral Bone Resection for Locally Recurrent Rectal Cancer.
    Takiguchi N; Uemura M; Kitakaze M; Paku M; Takeda M; Sekido Y; Hata T; Hamabe A; Ogino T; Miyoshi N; Tei M; Kagawa Y; Yamamoto H; Doki Y; Eguchi H
    Anticancer Res; 2023 Nov; 43(11):5061-5066. PubMed ID: 37909970
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Complications and 5-year survival after radical resections which include urological organs for locally advanced and recurrent pelvic malignancies: analysis of 646 consecutive cases.
    Peacock O; Waters PS; Kong JC; Warrier SK; Wakeman C; Eglinton T; Murphy DG; Heriot AG; Frizelle FA; McCormick JJ
    Tech Coloproctol; 2020 Feb; 24(2):181-190. PubMed ID: 31907722
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Surgery and pre-operative irradiation for locally advanced or recurrent rectal cancer in patients over 75 years of age.
    Larsen SG; Wiig JN; Tretli S; Giercksky KE
    Colorectal Dis; 2006 Mar; 8(3):177-85. PubMed ID: 16466556
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Pelvic exenteration in advanced and or recurrent rectal cancer].
    Koyama Y; Moriya Y; Hojo K
    Nihon Geka Gakkai Zasshi; 1987 Jan; 88(1):58-62. PubMed ID: 2434830
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Prognostic and predictive factors after surgical treatment for locally recurrent rectal cancer: a single institute experience.
    Asoglu O; Karanlik H; Muslumanoglu M; Igci A; Emek E; Ozmen V; Kecer M; Parlak M; Kapran Y
    Eur J Surg Oncol; 2007 Dec; 33(10):1199-206. PubMed ID: 17400423
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Treatment strategy for locally recurrent rectal cancer.
    Moriya Y
    Jpn J Clin Oncol; 2006 Mar; 36(3):127-31. PubMed ID: 16598032
    [TBL] [Abstract][Full Text] [Related]  

  • 70. What Constitutes a Clear Margin in Patients With Locally Recurrent Rectal Cancer Undergoing Pelvic Exenteration?
    Koh CE; Brown KGM; Steffens D; Young J; Salkeld G; Solomon MJ
    Ann Surg; 2022 Jan; 275(1):157-165. PubMed ID: 32068551
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Factors affecting outcomes following pelvic exenteration for locally recurrent rectal cancer.
    PelvEx Collaborative
    Br J Surg; 2018 May; 105(6):650-657. PubMed ID: 29529336
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Pelvic exenteration combined with sacral resection for recurrent rectal cancer. The roles of carcinoembryonic antigen and pelvic computed tomography for early detection].
    Takagi H; Morimoto T; Kato T; Yasue M; Kato K; Yamada E
    Nihon Geka Gakkai Zasshi; 1984 Feb; 85(2):153-9. PubMed ID: 6749100
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Learning curve for the management of recurrent and locally advanced primary rectal cancer: a single team's experience.
    Georgiou PA; Bhangu A; Brown G; Rasheed S; Nicholls RJ; Tekkis PP
    Colorectal Dis; 2015 Jan; 17(1):57-65. PubMed ID: 25204543
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Sacral recurrence of rectal carcinoma].
    Schumpelick V; Braun J
    Chirurg; 1995 Oct; 66(10):931-40. PubMed ID: 8529445
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Posterior pelvic exenteration for primary rectal cancer.
    Bannura GC; Barrera AE; Cumsille MA; Contreras JP; Melo CL; Soto DC; Mansilla JE
    Colorectal Dis; 2006 May; 8(4):309-13. PubMed ID: 16630235
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Sacral resection for control of pelvic tumors.
    Temple WJ; Ketcham AS
    Am J Surg; 1992 Apr; 163(4):370-4. PubMed ID: 1373043
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Survival after pelvic exenteration for T4 rectal cancer.
    Kusters M; Austin KK; Solomon MJ; Lee PJ; Nieuwenhuijzen GA; Rutten HJ
    Br J Surg; 2015 Jan; 102(1):125-31. PubMed ID: 25451182
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Pelvic exenteration: a treatment for failed rectal cancer surgery.
    Estes NC; Thomas JH; Jewell WR; Beggs D; Hardin CA
    Am Surg; 1993 Jul; 59(7):420-2. PubMed ID: 8323074
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Significance of local recurrence of rectal cancer as a local or disseminated disease.
    Maetani S; Onodera H; Nishikawa T; Morimoto H; Ida K; Kitamura O; Imamura M
    Br J Surg; 1998 Apr; 85(4):521-5. PubMed ID: 9607539
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A qualitative study of the development of a multidisciplinary case conference review methodology to reduce involved margins in pelvic exenteration surgery for recurrent rectal cancer.
    van Ramshorst GH; O'Shannassy S; Brown WE; Kench JG; Solomon MJ
    Colorectal Dis; 2018 Nov; 20(11):1004-1013. PubMed ID: 29920909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.